*.*.44.201
药智数据企业版
量身打造,体验升级
立即前往
VIP试用申请
登录 注册
当前位置: 首页 > NME和BLA(美国) 反馈纠错 帮助中心
药智数据企业版注册数据库:增设了"联合申报"、"临床试验默认许可日期"等搜索条件,让搜索页面纬度更加全面,还有热点搜索和高级条件组合检索等检索功能 等你来体验!
-
药品名称 批准类型 活性成分 适应症 上市发布公告 临床试验快照 批准日期 申请机构
Amvuttra vutrisiran To treat polyneuropathy of hereditary transthyretin-mediated amyloidosis 2022-06-13 Alnylam Pharmaceuticals, Inc
Vtama NME tapinarof To treat plaque psoriasis 2022-05-23 DERMAVANT SCIENCES INC
Mounjaro NME tirzepatide To improve blood sugar control in diabetes, in addition to diet and exercise Press Release 2022-05-13 ELI LILLY AND CO
Voquezna NME vonoprazan, amoxicillin, and clarithromycin To treat Helicobacter pylori infection 2022-05-03 Phathom Pharmaceuticals, Inc
Camzyos NME mavacamten To treat certain classes of obstructive hypertrophic cardiomyopathy 2022-04-28 MYOKARDIA INC
Vivjoa Biologics oteseconazole To reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are not of reproductive potential 2022-04-26 MYCOVIA PHARMACEUTICALS INC
Pluvicto NME lutetium (177Lu) vipivotide tetraxetan To treat prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer following other therapies 2022-03-23 AAA USA NOVARTIS
Opdualag Biologics nivolumab and relatlimab-rmbw To treat unresectable or metastatic melanoma 2022-03-18 BRISTOL MYERS SQUIBB
Ztalmy NME ganaxolone To treat seizures in cyclin-dependent kinase-like 5 deficiency disorder 2022-03-18 Marinus Pharmaceuticals, Inc
Vonjo NME pacritinib To treat intermediate or high-risk primary or secondary myelofibrosis in adults with low platelets 2022-02-28 CTI BIOPHARMA CORP
Pyrukynd NME mitapivat To treat hemolytic anemia in pyruvate kinase deficiency 2022-02-17 AGIOS PHARMS INC
Enjaymo Biologics sutimlimab-jome To decrease the need for red blood cell transfusion due to hemolysis in cold agglutinin disease 2022-02-04 BIOVERATIV THERAPEUTICS INC
Vabysmo Biologics faricimab-svoa To treat neovascular (wet) aged-related macular degeneration and diabetic macular edema 2022-01-28 GENENTECH INC
Kimmtrak Biologics tebentafusp-tebn To treat unresectable or metastatic uveal melanoma 2022-01-25 IMMUNOCORE LTD
Cibinqo NME abrocitinib To treat refractory, moderate-to-severe atopic dermatitis 2022-01-14 PFIZER
Quviviq NME daridorexant To treat insomnia 2022-01-07 IDORSIA PHARMACEUTICALS LTD.
Adbry Biologics tralokinumab-ldrm To treat moderate-to-severe atopic dermatitis 2021-12-27 LEO PHARMA AS
Leqvio NME inclisiran To treat heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease as an add-on therapy 2021-12-22 NOVARTIS
Tezspire Biologics tezepelumab-ekko To treat severe asthma as an add-on maintenance therapy 2021-12-17 ASTRAZENECA AB
Vyvgart Biologics efgartigimod alfa-fcab To treat generalized myasthenia gravis Press Release 2021-12-17 ARGENX BV